Dr. Noy on the Rationale to Evaluate Devimistat in Burkitt Lymphoma

2 Visninger
administrator
administrator
07/11/23

Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive

  • Kategori

Vis mere
0 Kommentarer Sorter efter

    Ingen kommentarer fundet

    Facebook kommentarer

    Næste

    Answers from the Experts: Pathology of Cutaneous Lymphoma
    00:51:04
    Answers from the Experts: Pathology of Cutaneous Lymphoma
    administrator
    14 Visninger
    Dos and Don'ts Cutaneous T Cell Lymphoma - a type of blood cancer
    00:05:30
    Dos and Don'ts Cutaneous T Cell Lymphoma - a type of blood cancer
    administrator
    6 Visninger
    T-Cell Lymphoma with Barbara Pro, MD | Everything You Need to Know
    00:07:31
    T-Cell Lymphoma with Barbara Pro, MD | Everything You Need to Know
    administrator
    4 Visninger
    EuroBloodNet's Topic on focus: Cutaneous Lymphoma - CD30+lymphoproliferations
    00:37:15
    EuroBloodNet's Topic on focus: Cutaneous Lymphoma - CD30+lymphoproliferations
    administrator
    5 Visninger
    Meet Michelle: T-Cell Lymphoma Survivor
    00:04:15
    Meet Michelle: T-Cell Lymphoma Survivor
    administrator
    4 Visninger
    #Cutaneous T cell lymphoma #PET/CT
    00:00:09
    #Cutaneous T cell lymphoma #PET/CT
    administrator
    2 Visninger
    Cutaneous Lymphoma Catalyst Research Grant Recipients
    00:12:19
    Cutaneous Lymphoma Catalyst Research Grant Recipients
    administrator
    5 Visninger
    Treatments Cutaneous T Cell Lymphoma - a type of blood cancer
    00:05:47
    Treatments Cutaneous T Cell Lymphoma - a type of blood cancer
    administrator
    3 Visninger
    Future directions for checkpoint inhibitors in cutaneous lymphoma treatment
    00:01:35
    Future directions for checkpoint inhibitors in cutaneous lymphoma treatment
    administrator
    2 Visninger
    Doc Talk: Cutaneous Lymphoma
    00:00:58
    Doc Talk: Cutaneous Lymphoma
    administrator
    4 Visninger
    Answers from the Experts: Cutaneous B-Cell Lymphoma Variants
    00:04:41
    Answers from the Experts: Cutaneous B-Cell Lymphoma Variants
    administrator
    3 Visninger
    CD30+ cutaneous T-cell lymphoma (Medical Condition)
    00:00:39
    CD30+ cutaneous T-cell lymphoma (Medical Condition)
    administrator
    5 Visninger
    T-cell Lymphoma
    00:19:42
    T-cell Lymphoma
    administrator
    9 Visninger
    16- Cases (Part 3) - Cutaneous T Cell Lymphoma Made Easy
    00:37:43
    16- Cases (Part 3) - Cutaneous T Cell Lymphoma Made Easy
    administrator
    6 Visninger
    Diagnosis of Cutaneous T Cell Lymphoma - a type of blood cancer
    00:04:46
    Diagnosis of Cutaneous T Cell Lymphoma - a type of blood cancer
    administrator
    9 Visninger
    EuroBloodNet's Topic on focus: Cutaneous Lymphoma - Mycosis Fungoides
    00:46:55
    EuroBloodNet's Topic on focus: Cutaneous Lymphoma - Mycosis Fungoides
    administrator
    1 Visninger
    Optimising outcomes in cutaneous T-cell lymphoma: Dr. Pier Luigi Zinzani (Italy) - 08 Oct 2021
    00:25:18
    Optimising outcomes in cutaneous T-cell lymphoma: Dr. Pier Luigi Zinzani (Italy) - 08 Oct 2021
    administrator
    5 Visninger
    Dr. Zain on Investigational Approaches in Peripheral T-Cell Lymphoma
    00:01:37
    Dr. Zain on Investigational Approaches in Peripheral T-Cell Lymphoma
    administrator
    9 Visninger
    EuroBloodNet's Topic on focus: Cutaneous Lymphoma - Introduction to CL
    00:44:17
    EuroBloodNet's Topic on focus: Cutaneous Lymphoma - Introduction to CL
    administrator
    2 Visninger